*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
A Study Of Efficacy Of Autologous Platelet Rich Plasma In The Treatment Of Chronic Diabetic Foot Ulcers

Author: MADHUMITHA.M , SUNDARAMORTHY SRINIVASAN
Abstract: Diabetic foot ulcers are a communal health problematic around the world. Often it becomes chronic and nonhealing causing significant distress to the patient physically, mentally and financially. Its management is challenging especially in developing countries like India, where there is inadequate health resources and poor health awareness among the public. Its global burden is increasing and various treatment modalities are available for treating diabetic foot ulcers. One novel therapy recently gaining interest is the Platelet Rich Plasma (PRP) therapy. This study evaluates the efficacy of PRP in the treatment of chronic diabetic foot ulcers. A total of 42 patients were registered in the study. They were arbitrarilyseparated into two groups. One group is the PRP Group, where glycemic control, cleansing with normal saline, debridement of the wound, application of platelet rich plasma and treatment of infection was carried out. The other group was the Control Group, where glycemic control, cleansing with normal saline, debridement of the wound and treatment of infection was carried out. The ulcer was measured at the end of each week and area was calculated for both the groups. This was done for a total duration of five weeks. The percentage improvement in area was calculated and compared for both groups. Male patients (71.4%) were encountered more than female patients (28.6%) in both the groups. The most common age group affected was 51 to 60 years in both the groups (50%). The duration of ulcer for majority of the patients was between 8 weeks and 16 weeks in PRP as well as control group (54.8%). The most common site affected was sub-metatarsal region seen in both groups (35.7%). Majority of the patients were found to be farmers in both the groups (28.6%). At the end of five weeks, the mean percentage development in area was found to be 82.19% in the PRP group and 37.50% in the control group.Ulcer healing was found to be better and faster in the PRP group than that of control group, proving the superior efficacy of platelet rich plasma therapy. Thus, Platelet rich plasma therapy is a simple, cheap and effective day care procedure which can be used safely for treating chronic nonhealing diabetic foot ulcers.
Keyword: Diabetes mellitus,autologous platelet,Ulcer healing,foot ulcers,Platelet rich plasma,glycemic control
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free